Market Analysis and Insights: Global Luer Lock Syringe Market
Due to the COVID-19 pandemic, the global Luer Lock Syringe market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Up to 1 ml accounting for % of the Luer Lock Syringe global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospital segment is altered to an % CAGR throughout this forecast period.
China Luer Lock Syringe market size is valued at US$ million in 2021, while the US and Europe Luer Lock Syringe are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Luer Lock Syringe landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Luer Lock Syringe include AdvaCare Pharma, Nipro Europe Group Companies, Terumo Europe NV (Terumo Pharmaceutical Solutions), COMPET MEDICAL, Becton Dickinson, Gerresheimer AG, IndoSurgicals Private, Advin Health Care and Sign For Safety, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Luer Lock Syringe Scope and Segment
Luer Lock Syringe market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Luer Lock Syringe market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Up to 1 ml
2 ml to 10 ml
11 ml to 20 ml
Above 20 ml
Segment by Application
Hospital
Clinic
Other
By Company
AdvaCare Pharma
Nipro Europe Group Companies
Terumo Europe NV (Terumo Pharmaceutical Solutions)
COMPET MEDICAL
Becton Dickinson
Gerresheimer AG
IndoSurgicals Private
Advin Health Care
Sign For Safety
Mediplus India
Medis Medical
Swastik Enterprise
Anatco Enterprises
Forlong Medical
Taisei Kako
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Due to the COVID-19 pandemic, the global Luer Lock Syringe market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Up to 1 ml accounting for % of the Luer Lock Syringe global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospital segment is altered to an % CAGR throughout this forecast period.
China Luer Lock Syringe market size is valued at US$ million in 2021, while the US and Europe Luer Lock Syringe are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Luer Lock Syringe landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Luer Lock Syringe include AdvaCare Pharma, Nipro Europe Group Companies, Terumo Europe NV (Terumo Pharmaceutical Solutions), COMPET MEDICAL, Becton Dickinson, Gerresheimer AG, IndoSurgicals Private, Advin Health Care and Sign For Safety, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Luer Lock Syringe Scope and Segment
Luer Lock Syringe market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Luer Lock Syringe market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Up to 1 ml
2 ml to 10 ml
11 ml to 20 ml
Above 20 ml
Segment by Application
Hospital
Clinic
Other
By Company
AdvaCare Pharma
Nipro Europe Group Companies
Terumo Europe NV (Terumo Pharmaceutical Solutions)
COMPET MEDICAL
Becton Dickinson
Gerresheimer AG
IndoSurgicals Private
Advin Health Care
Sign For Safety
Mediplus India
Medis Medical
Swastik Enterprise
Anatco Enterprises
Forlong Medical
Taisei Kako
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Frequently Asked Questions
This market study covers the global and regional market with an
in-depth analysis of the
overall growth prospects...
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by
highlighting information on
different aspects including drivers, restraints...
Pre-order Enquiry
Download Free Sample








